Kevin Klucher
Senior Director, Biology


Dr. Klucher has over 15 years experience in drug development. Prior to joining Terns Pharmaceuticals, he was Director of Biology at Oncothyreon, where he led discovery and translational research of numerous small molecule and vaccine therapeutics for cancer. Before Oncothyreon, Dr. Klucher was a Principal Scientist at ZymoGenetics, where he was responsible for the discovery and early development of protein therapeutics for multiple clinical indications including oncology and viral diseases.

Dr. Klucher received his Ph.D. in biology from the University of California, San Diego. He completed post-doctoral studies at the University of California, Berkeley and the Whitehead Institute.